Liabilities and Equity of Nu-Med Plus, Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Nu-Med Plus, Inc. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • Nu-Med Plus, Inc. Liabilities and Equity for the quarter ending 31 Dec 2024 was $9,373, a 30% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Nu-Med Plus, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $9,373 -$4,083 -30% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $6,841 -$6,907 -50% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q1 2024 $9,016 -$50,053 -85% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $13,456 -$66,089 -83% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $13,748 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $36,547 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $59,069 +$51,143 +645% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $79,545 +$57,382 +259% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q1 2022 $7,926 -$277,087 -97% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $22,163 -$534,972 -96% 31 Dec 2021 10-K/A 03 Apr 2023 2022 FY
Q3 2021 $51,236 -$598,325 -92% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $89,130 -$763,108 -90% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $285,013 +$237,794 +504% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $557,135 +$511,356 +1117% 31 Dec 2020 10-K/A 11 Apr 2022 2021 FY
Q3 2020 $649,561 +$565,894 +676% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $852,238 +$799,453 +1515% 30 Jun 2020 10-Q 19 Aug 2020 2020 Q2
Q1 2020 $47,219 -$107,282 -69% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $45,779 -$377,237 -89% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $83,667 -$468,784 -85% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $52,785 -$283,927 -84% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $154,501 -$170,510 -52% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $423,016 +$16,297 +4% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $552,451 +$93,043 +20% 30 Sep 2018 10-Q 19 Nov 2018 2018 Q3
Q2 2018 $336,712 +$19,493 +6.1% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 $325,011 -$24,737 -7.1% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 $406,719 +$371,186 +1045% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $459,408 +$206,526 +82% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 $317,219 -$627,943 -66% 30 Jun 2017 10-Q 18 Aug 2017 2017 Q2
Q1 2017 $349,748 +$222,569 +175% 31 Mar 2017 10-Q 17 May 2017 2017 Q1
Q4 2016 $35,533 -$40,412 -53% 31 Dec 2016 10-K 03 Apr 2018 2017 FY
Q3 2016 $252,882 +$190,161 +303% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $945,162 +$854,341 +941% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 $127,179 +$26,549 +26% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 $75,945 -$137,117 -64% 31 Dec 2015 10-K 19 Apr 2017 2016 FY
Q3 2015 $62,721 -$150,341 -71% 30 Sep 2015 10-Q 23 Nov 2015 2015 Q3
Q2 2015 $90,821 -$452,708 -83% 30 Jun 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 $100,630 -$400,887 -80% 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q4 2014 $213,062 +$117,040 +122% 31 Dec 2014 10-K 13 Apr 2016 2015 FY
Q3 2014 $213,062 +$146,431 +220% 30 Sep 2014 10-Q 23 Nov 2015 2015 Q3
Q2 2014 $543,529 +$473,734 +679% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 $501,517 +$431,371 +615% 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q4 2013 $96,022 -$14,381 -13% 31 Dec 2013 10-K 23 Mar 2015 2014 FY
Q3 2013 $66,631 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 $69,795 30 Jun 2013 10-Q 13 Aug 2013 2013 Q2
Q1 2013 $70,146 31 Mar 2013 10-Q 14 May 2013 2013 Q1
Q4 2012 $110,403 +$108,997 +7752% 31 Dec 2012 10-K 21 Feb 2014 2013 FY
Q4 2011 $1,406 31 Dec 2011 10-K 28 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.